Navigation Links
Restricting Blood Flow May Help Heart Bypass Patients
Date:8/18/2007

after stent implantation in patients with coronary artery is safe," the researchers wrote.

In addition, they say that unlike another cox-2 inhibitor, Vioxx, celecoxib does not increase the risk of heart attack. "Administration of celecoxib for six months does not seem to increase the risk of adverse cardiac events in the intermediate term when used with dual anti-platelet therapy," they wrote.

However, another accompanying journal editorial warned that clinical trials suggest that long-term use of celecoxib may increase the risk of heart attack.

More information

To learn more about bypass surgery, visit the American Heart Association.



SOURCES: Derek Yellon, M.D., and Derek J. Hausenloy, M.D., Ph.D., both Hatter Cardiovascular Institute, University College London; Henry Purcell, M.D., Royal Brompton Hospital, London; Aug. 18, 2007, The Lancet


'/>"/>

Copyright©2007 ScoutNews,LLC.

1

GOOD

Page: 1 2 3

Related medicine news :

1. New Zealand Doctors for Restricting Trampoline Sales
2. Recommendations for Treatment of Blood Pressue
3. Blood Cells Capable of Regenerating Liver
4. Infant receives first bloodless liver transplant
5. Spouses and other partners lower blood pressure says new research
6. H2O - a cure for low blood pressure
7. Uncontrolled blood pressure
8. Nitric oxide involved in high blood pressure
9. Recouping blood flow after a stroke
10. Way to monitor blood pressure
11. Blood clots likely in long travel
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 1Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 2Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 3Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 4Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 1Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 2Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 3Centegra H1N1 Vaccination Clinics to Resume Tuesday Dec 1 62154 4MISSION Skincare 28R 29 Supports GNCs Efforts To Raise Money for St Jude Childrens Research Hospital 28R 29 62150 1MISSION Skincare 28R 29 Supports GNCs Efforts To Raise Money for St Jude Childrens Research Hospital 28R 29 62150 2